Rights and permissions
About this article
Cite this article
Two combination regimens added to NCCN ovarian cancer guidelines. Pharmacoecon. Outcomes News 596, 3 (2010). https://doi.org/10.2165/00151234-201005960-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201005960-00009